Literature DB >> 21696415

BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults.

M Hasselblatt1, B Riesmeier, B Lechtape, A Brentrup, W Stummer, F K Albert, A Sepehrnia, H Ebel, J Gerss, W Paulus.   

Abstract

AIM: Duplication of 7q34 resulting in generation of BRAF-KIAA1549 fusion transcripts is a characteristic event in pilocytic astrocytoma that may also aid distinction from diffuse astrocytic tumours. As data on BRAF-KIAA1549 fusion transcript status remain mainly limited to children, we aimed to examine the diagnostic value of BRAF-KIAA1549 fusion transcripts across all age groups.
METHODS: BRAF-KIAA1549 fusion transcript status was examined using reverse transcription polymerase chain reaction on formalin-fixed paraffin-embedded samples of 105 primary pilocytic astrocytomas [median patient age: 17 years (1-74 years)].
RESULTS: Informative results (distinct wildtype BRAF bands detectable) were obtained in 105/124 cases (85%). Fusion transcripts were detected in 53 of cases (51%). They were more often encountered in tumours of infratentorial location [42/67 (63%) vs. 11/38 (29%)] and comprised KIAA1549-Ex16_BRAF-Ex9 (32 cases), KIAA1549-Ex15_BRAF-Ex9 (14 cases) and KIAA1549-Ex16_BRAF-Ex11 (seven cases). Fusion transcripts were present in 79% of tumours diagnosed in the first decade of life, but only in 51% of patients aged 11-20 years, 42% of patients aged 21-30 years, 30% of patients aged 31-40 years and 7% of patients older than 40 years. On multivariate logistic regression analysis, the association of fusion transcript status and age was confirmed adjusting for tumour location (P = 0.006).
CONCLUSIONS: The frequency of BRAF-KIAA1549 fusion transcripts is significantly lower in adult patients with pilocytic astrocytoma, weakening the sensitivity of this specific diagnostic marker in that age group.
© 2011 The Authors. Neuropathology and Applied Neurobiology © 2011 British Neuropathological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21696415     DOI: 10.1111/j.1365-2990.2011.01193.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  33 in total

1.  Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups.

Authors:  Hetakshi Kurani; Mamta Gurav; Omshree Shetty; Girish Chinnaswamy; Aliasagar Moiyadi; Tejpal Gupta; Rakesh Jalali; Sridhar Epari
Journal:  Childs Nerv Syst       Date:  2019-07-18       Impact factor: 1.475

Review 2.  To BRAF or not to BRAF: is that even a question anymore?

Authors:  Craig Horbinski
Journal:  J Neuropathol Exp Neurol       Date:  2013-01       Impact factor: 3.685

3.  Adult pilocytic astrocytomas: clinical features and molecular analysis.

Authors:  Brett J Theeler; Benjamin Ellezam; Zsila S Sadighi; Vidya Mehta; M Diep Tran; Adekunle M Adesina; Janet M Bruner; Vinay K Puduvalli
Journal:  Neuro Oncol       Date:  2014-01-26       Impact factor: 12.300

4.  [Molecular diagnostics in neuropathology].

Authors:  W Dietmaier; J Lorenz; M J Riemenschneider
Journal:  Pathologe       Date:  2015-03       Impact factor: 1.011

Review 5.  Molecular markers of glioma: an update on recent progress and perspectives.

Authors:  Kirti Gupta; Pravin Salunke
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-06       Impact factor: 4.553

6.  BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants.

Authors:  Alex Lin; Fausto J Rodriguez; Matthias A Karajannis; Susan C Williams; Genevieve Legault; David Zagzag; Peter C Burger; Jeffrey C Allen; Charles G Eberhart; Eli E Bar
Journal:  J Neuropathol Exp Neurol       Date:  2012-01       Impact factor: 3.685

Review 7.  Molecular markers in pediatric neuro-oncology.

Authors:  Koichi Ichimura; Ryo Nishikawa; Masao Matsutani
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

8.  Something old and something new about molecular diagnostics in gliomas.

Authors:  Craig Horbinski
Journal:  Surg Pathol Clin       Date:  2012-12-01

9.  Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas.

Authors:  Angela J Sievert; Shih-Shan Lang; Katie L Boucher; Peter J Madsen; Erin Slaunwhite; Namrata Choudhari; Meghan Kellet; Phillip B Storm; Adam C Resnick
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

10.  IDH1 R132H mutation in a pilocytic astrocytoma: a case report.

Authors:  Felix Behling; Julia Steinhilber; Marcos Tatagiba; Sotirios Bisdas; Jens Schittenhelm
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.